Chargement de l’entreprise
Keep exploring
The themes Johnson & Johnson is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The themes it is part of
- Sélection
Medical devices
Par InspectStocks · 20 companies
Surgical robots, implants, heart devices, glucose monitors and other medical equipment.
- Cours, 1 an
- +6,2 %
- Chiffre d’affaires, 1 an
- +7,2 %
+14A 8B 7C 3D 2
- Sélection
Big pharma
Par InspectStocks · 13 companies
The largest drugmakers, selling prescription medicines worldwide.
- Cours, 1 an
- +41,6 %
- Chiffre d’affaires, 1 an
- +10,8 %
+7A 7B 3C 3
Highest-graded in Drug Manufacturers General
Graded A or B and worth $2B or more: A first, then the largest.
- LLYELI Lilly And Company1,36T $USA+
- MRKMerck & Co., Inc.364,3B $USA
- NVSNovartis AG306,3B $USA
AMGNAmgen Inc.251,9B $USA+
GILDGilead Sciences, Inc.208,4B $USA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 oct. 2026CBGraded C, now B
MCKMckesson Corporation4 nov. 2026BAGraded B, now A
CVSCVS Health Corp4 nov. 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 nov. 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 oct. 2026CAGraded C, now A
Comment elle gagne de l'argent
- Innovative Medicine64 %
- MedTech36 %
Les parts du chiffre d'affaires sont des estimations pour six months ended June 28, 2026, high confidence, pas des chiffres tirés d'un document officiel.
En concurrence avec
Ce qu'elle vend6
DARZALEX
A medicine used to treat multiple myeloma, a cancer of plasma cells.
TREMFYA
A medicine for conditions including plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
CARVYKTI
A treatment made from a patient’s modified immune cells for multiple myeloma that has returned or has not responded to earlier treatment.
Afficher 3 de plus
VARIPULSE
A system that uses pulsed electrical energy to treat atrial fibrillation, a disorder that causes an irregular heartbeat.
Impella
A heart pump used to support blood circulation in certain patients with heart failure or during high-risk heart procedures.
ACUVUE
A brand of contact lenses sold for vision correction.
Qui l'achète4
- Wholesalers, distributors and retailers that buy medicines and medical products for resale.
- Hospitals and clinics that buy medicines and devices for patient care and procedures.
- Physicians and other healthcare professionals who prescribe medicines or use medical devices in treatment.
- Eye-care professionals and retailers that supply contact lenses and other vision products.
Sur quoi elle repose, et ce qui pourrait la briser
Ce dont l'activité dépend
- 1Some medicines rely on licenses or partnerships with other companies. For example, a subsidiary licenses patent families related to DARZALEX from Genmab, and IMBRUVICA is co-commercialized in the United States with Pharmacyclics, an AbbVie company.
- 2The company depends on government approvals and ongoing oversight for its medicines and medical devices, including rules on safety, manufacturing, labeling and sales.
- 3Sales depend partly on health insurers and government programs deciding whether to cover products and how much they will reimburse; U.S. and other governments can also change medicine-pricing rules.
- 4The company uses third parties to make or supply some products and relies on complex international manufacturing and distribution chains.
Ce qui pourrait mal tourner
- 1Generic and biosimilar competition can reduce sales of medicines when alternatives enter the market. The latest quarterly report describes continuing sales declines for STELARA and says biosimilar competition is also affecting other medicines.
- 2Government pricing rules, coverage decisions and reimbursement changes can affect what the company receives for medicines and medical devices. The company identifies U.S. drug-pricing measures and tighter regulation across markets as concerns.
- 3Lawsuits and product-safety claims can lead to substantial costs and affect sales or reputation. The latest quarterly report recorded charges related to talc litigation.
À propos de Johnson & Johnson
Johnson & Johnson develops, makes and sells prescription medicines and medical devices around the world. Its two businesses are Innovative Medicine, which sells medicines for conditions including cancer and immune disorders, and MedTech, which sells products used in heart procedures, surgery, orthopaedics and vision care.
- Siège
- New Brunswick, New Jersey
- Fondée en
- 1887 (founding year, high confidence)
- Effectif
- 140,800 (December 28, 2025, high confidence)
- Cotée sur
- New York Stock Exchange
- Clôture de l'exercice
- Last Sunday in December
Construit à partir des documents déposés par Johnson & Johnson auprès de la Securities and Exchange Commission (SEC), le gendarme boursier américain. Les chiffres sont tels que publiés, l’historique par action étant retraité sur la base d’actions d’aujourd’hui. Ceci décrit une entreprise — ce n’est pas un conseil en investissement ni une recommandation d’acheter ou de vendre.